Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06537596
What this trial is testing

89Zr-olaratumab Dosimetry in Participants With PDGFR Alpha Positive Solid Tumours and Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaPDGFR Alpha Positive Solid Tumours
Telix Pharmaceuticals (Innovations) Pty Ltd 50
Testing effectiveness (Phase 2)Study completedNCT00002974
What this trial is testing

Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma

Who this might be right for
Sarcoma
University of Wisconsin, Madison 34
Testing effectiveness (Phase 2)Looking for participantsNCT04515459
What this trial is testing

Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma

Who this might be right for
Sarcoma
Institut Claudius Regaud 53
Not applicableStudy completedNCT03964896
What this trial is testing

Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy

Who this might be right for
Breast CarcinomaHead and Neck CarcinomaSarcoma
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Looking for participantsNCT06735820
What this trial is testing

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

Who this might be right for
Malignant Peripheral Nerve Sheath Tumor (MPNST)Neurofibromatosis 1 (NF1)Atypical Neurofibroma
AeRang Kim 45
Early research (Phase 1)Study completedNCT00006246
What this trial is testing

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more
Pediatric Brain Tumor Consortium 28
Post-approval studies (Phase 4)Enrolling By InvitationNCT03244020
What this trial is testing

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Who this might be right for
SarcomaSoft Tissue SarcomaBone Sarcoma+4 more
Massachusetts General Hospital 2,868
Testing effectiveness (Phase 2)Study completedNCT00032162
What this trial is testing

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+2 more
AGO Study Group 63
Early research (Phase 1)Ended earlyNCT00036855
What this trial is testing

Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaPost-transplant Lymphoproliferative Disorder+4 more
National Cancer Institute (NCI) 36
Not applicableUnknownNCT05310318
What this trial is testing

Prognosis of Low-grade Endometrial Stromal Sarcoma

Who this might be right for
Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis)Fertility-sparing SurgerySurvival Outcomes+4 more
Lei Li 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04022213
What this trial is testing

The Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum

Who this might be right for
Desmoplastic Small Round Cell TumorPeritoneal CancerPeritoneal Carcinoma
Memorial Sloan Kettering Cancer Center 31
Testing effectiveness (Phase 2)UnknownNCT02732678
What this trial is testing

Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)

Who this might be right for
Angiosarcoma
Assistance Publique Hopitaux De Marseille 24
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Large-scale testing (Phase 3)Study completedNCT00003350
What this trial is testing

Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma

Who this might be right for
AIDS-related Kaposi Sarcoma
National Cancer Institute (NCI) 240
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT01585649
What this trial is testing

PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma

Who this might be right for
Ewing Family of Tumors, Rhabdomyosarcoma
Merckle GmbH 21
Not applicableWithdrawnNCT03660540
What this trial is testing

Spine and Tumor Screening and Supplementation

Who this might be right for
Spinal InjuriesSarcomaNutritional Deficiency
University of Iowa
Testing effectiveness (Phase 2)Study completedNCT00003116
What this trial is testing

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Case Comprehensive Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT00118352
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+61 more
Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03307616
What this trial is testing

Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery

Who this might be right for
Dedifferentiated LiposarcomaRecurrent Dedifferentiated LiposarcomaRecurrent Undifferentiated Pleomorphic Sarcoma+3 more
M.D. Anderson Cancer Center 32
Next Page